FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 132 filers reported holding FLEXION THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $44,117,000 | +10.9% | 3,823,000 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $39,797,000 | -20.8% | 3,823,000 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $50,272,000 | +154.4% | 3,823,000 | +52.3% | 0.01% | +100.0% |
| Q1 2020 | $19,759,000 | -62.0% | 2,510,700 | 0.0% | 0.01% | -50.0% |
| Q4 2019 | $51,971,000 | +51.0% | 2,510,700 | 0.0% | 0.01% | +50.0% |
| Q3 2019 | $34,409,000 | +11.4% | 2,510,700 | 0.0% | 0.01% | +14.3% |
| Q2 2019 | $30,882,000 | -1.4% | 2,510,700 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $31,334,000 | +17.7% | 2,510,700 | +6.7% | 0.01% | +14.3% |
| Q4 2018 | $26,633,000 | -39.5% | 2,352,700 | 0.0% | 0.01% | -36.4% |
| Q3 2018 | $44,019,000 | -40.7% | 2,352,700 | -18.1% | 0.01% | -31.2% |
| Q2 2018 | $74,241,000 | +15.3% | 2,872,000 | 0.0% | 0.02% | +14.3% |
| Q1 2018 | $64,362,000 | -10.5% | 2,872,000 | 0.0% | 0.01% | -12.5% |
| Q4 2017 | $71,915,000 | +17.2% | 2,872,000 | +13.2% | 0.02% | +14.3% |
| Q3 2017 | $61,369,000 | +19.6% | 2,538,000 | 0.0% | 0.01% | +16.7% |
| Q2 2017 | $51,318,000 | -23.4% | 2,538,000 | +2.0% | 0.01% | -25.0% |
| Q1 2017 | $66,979,000 | +44.7% | 2,489,000 | +2.3% | 0.02% | +33.3% |
| Q4 2016 | $46,276,000 | +37.4% | 2,433,000 | +41.2% | 0.01% | +33.3% |
| Q3 2016 | $33,668,000 | +30.6% | 1,723,051 | 0.0% | 0.01% | +28.6% |
| Q2 2016 | $25,785,000 | +62.7% | 1,723,051 | 0.0% | 0.01% | +75.0% |
| Q1 2016 | $15,852,000 | -51.7% | 1,723,051 | +1.2% | 0.00% | -55.6% |
| Q4 2015 | $32,821,000 | +29.7% | 1,703,194 | 0.0% | 0.01% | +28.6% |
| Q3 2015 | $25,309,000 | -20.7% | 1,703,194 | +16.9% | 0.01% | -22.2% |
| Q2 2015 | $31,903,000 | -0.2% | 1,457,446 | +2.7% | 0.01% | 0.0% |
| Q1 2015 | $31,962,000 | +11.5% | 1,419,252 | 0.0% | 0.01% | +12.5% |
| Q4 2014 | $28,655,000 | +60.3% | 1,419,252 | +44.9% | 0.01% | +60.0% |
| Q3 2014 | $17,881,000 | +76.9% | 979,252 | +30.6% | 0.01% | +66.7% |
| Q2 2014 | $10,110,000 | -14.9% | 750,000 | +3.8% | 0.00% | 0.0% |
| Q1 2014 | $11,880,000 | – | 722,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clearline Capital LP | 391,076 | $7,317,000 | 4.33% |
| Rubric Capital Management LP | 2,125,000 | $39,759,000 | 4.20% |
| Gagnon Advisors, LLC | 225,062 | $4,211,000 | 2.52% |
| GAGNON SECURITIES LLC | 450,655 | $8,432,000 | 1.94% |
| MILLER VALUE PARTNERS, LLC | 2,881,200 | $53,907,000 | 1.74% |
| PECONIC PARTNERS LLC | 222,965 | $4,172,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 415,000 | $7,765,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 532,812 | $9,969,000 | 1.00% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 574,483 | $10,749,000 | 0.75% |
| Kerrisdale Advisers, LLC | 37,145 | $695,000 | 0.68% |